Doctor Rafaela Del Carmen Ramirez Rodriguez

University Hospital of Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria (Spain)

Follow

Contributor content

Cardiac resynchronization therapy in diabetic patients improves survival in the group of patients with atrial fibrillation in the first twelve years. Long term follow-up.

Presentation

Cardiac resynchronization therapy in diabetic patients improves survival in the group of patients with atrial fibrillation in the first twelve years. Long term follow-up.

Effects of cardiac resyncrhonization therapy pacemaker versus cardiac resyncrhonization therapy implantable cardioverter defibrillator. Long term follow up

Presentation

Effects of cardiac resyncrhonization therapy pacemaker versus cardiac resyncrhonization therapy implantable cardioverter defibrillator. Long term follow up

Comparative study between upgrade and de novo cardiac resyncrhonization therapy. Long term follow up

Presentation

Comparative study between upgrade and de novo cardiac resyncrhonization therapy. Long term follow up

Do we need to use cardiac resynchronization therapy pacemaker more? Comparative study to cardiac resyncrhonization therapy defibrillator.

Presentation

Do we need to use cardiac resynchronization therapy pacemaker more? Comparative study to cardiac resyncrhonization therapy defibrillator.

Is the upgrade with respect to de novo cardiac resyncrhonization therapy effective? Long term comparative study

Presentation

Is the upgrade with respect to de novo cardiac resyncrhonization therapy effective? Long term comparative study

Effects of upgrade versus de novo cardiac resyncrhonization therapy on clinical response. Long term survival follow up from single center.

Presentation

Effects of upgrade versus de novo cardiac resyncrhonization therapy on clinical response. Long term survival follow up from single center.

Could patients over 85 years benefit of cardiac resynchronization pacemaker?

Presentation

Could patients over 85 years benefit of cardiac resynchronization pacemaker?

Response to cardiac resyncrhonization therapy in elderly patients (85 years). Long term follow-up.

Presentation

Response to cardiac resyncrhonization therapy in elderly patients (85 years). Long term follow-up.

Survival of patients with biventricular devices after device infection

Presentation

Survival of patients with biventricular devices after device infection

Device infection and survival of patients with biventricular devices

Presentation

Device infection and survival of patients with biventricular devices

ESC 365 is supported by

novartis

Explore sponsored resources